🔎 Trials Near Me

Почетна › Рак плућа › Јута › Salt Lake City

Kliničke studije za Рак плућа u gradu Salt Lake City, UT

19 studija za Рак плућа traži učesnike na lokacijama u gradu Salt Lake City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Тражи се учесникФаза 2/3
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07063745

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Тражи се учесникФаза 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07458347

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Тражи се учесникФаза 1/2
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Тражи се учесникФаза 3
  • Huntsman Cancer Institute ( Site 0042), Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06312137

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Тражи се учесникФаза 2/3
  • Utah Cancer Specialists, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06712316

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Тражи се учесникФаза 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06922591

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Тражи се учесникФаза 1/2
  • University of Utah, Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • University of Utah, Salt Lake City
  • Veterans Affairs SLC Health Care System (VAMC), Salt Lake City
Узраст 21 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07460440

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Тражи се учесникФаза 1
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Тражи се учесникФаза 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06500481

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

Тражи се учесникЗдраве особе су добродошле
  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
Узраст од 50 до 80 · Оба пола · Ажурирано 21. 7. 2026. · NCT07716280

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Тражи се учесникФаза 1/2
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 15. 5. 2026. · NCT05379985

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Тражи се учесник
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT05297734

Improving Care for Rural Patients With Solid Tumors

Тражи се учесник
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 2. 2026. · NCT04916990

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Salt Lake City
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Рак плућа u drugim gradovima

Ostale studije u gradu Salt Lake City

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.